Senores Pharmaceuticals Ltd has made a significant move by acquiring a 70% stake in Amerisyn LLC, a US-based pharmaceutical company established in March 2026. This step establishes a new subsidiary within the Senores group structure.

Senores Pharmaceuticals Ltd promoters increased their stake by acquiring 11.7 lakh convertible equity warrants through a preferential allotment, now holding 47.16% of the diluted voting capital, up from the previous 44.68%.